Charles River Laboratories International (NYSE:CRL – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Thursday. Several other analysts have also recently issued reports on the company. Robert W. Baird dropped their target price on Charles River Laboratories International from $282.00 […]